search
Back to results

Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS

Primary Purpose

Amyotrophic Lateral Sclerosis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Expiratory Muscle Strength Training (EMST-150)
Sponsored by
Purdue University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Amyotrophic Lateral Sclerosis

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of ALS
  • Within the early stages of disease progression (i.e., able to talk, breathe, and eat independently)
  • Speaker of English
  • Have a family member/caregiver willing to assist as needed
  • Have access to an electronic device and internet for tele-health

Exclusion Criteria:

  • A history of neurological disease (besides ALS)
  • A history of asthma or respiratory problems (e.g., COPD, emphysema)
  • A history of head, neck, or chest surgery (except mastectomy)
  • A history of smoking within the last 5 years
  • Reliance on mechanical ventilation (including CPAP)

Sites / Locations

  • Purdue University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Expiratory Muscle Strength Training

Arm Description

All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).

Outcomes

Primary Outcome Measures

Change From Baseline to Post-treatment for Maximum Expiratory Pressure
Change in expiratory muscle strength throughout the study duration measured by the participant blowing into a pressure meter

Secondary Outcome Measures

Peak Expiratory Flow Rate
Change in cough strength (as measured by peak expiratory flow rate) throughout the study duration, measured using a flow meter that the participant coughs into - single coughs. Data from baseline 2 and pre-training were averaged for the pre--training value.
Change From Baseline to Post-Treatment in Utterance Length
Change in utterance length (# of syllables produced on one breath) throughout the study duration. Participant read the Rainbow Passage and data were collected from this task.
Change From Baseline to Post-Treatment in Number of Pauses
Change in the total number of pauses that included breathing (breath pauses). Participant read the Rainbow Passage and data were collected from this task.
Change From Baseline to Post-Treatment in Syntactic Location of Pauses
Change in the location of pauses while breathing produced while reading. We determined where participants took breaths while reading the Rainbow Passage and categorized them according to syntax. Categories included at a major boundary (at the end of an independent clause marked by a period) and at a boundary that is not related to syntax (not a major or minor syntactical location). The number of pauses at each category of boundaries were converted to a percent of the total breaths taken while reading the passage.
Telehealth Satisfaction
Participants rated 15 statements with a 5-point Likert scale ranging from strongly disagree (1) to strongly agree (5). Example statements include: I can easily talk to my health-care provider, I can hear my health-care provider clearly, I can see my health-care provider as if we met in person, I think the care provided via telemedicine is consistent, and I receive adequate attention, telemedicine provides for my health care need, and overall, I am satisfied with the quality of service being provided via telemedicine. Total scores range from 0-75 and individual statement scores ranged from 1-5, with higher scores indicating higher satisfaction with the telepractice modality.
Change From Pre-Training to Post-Training in Communication Participation Item Bank
Participants were instructed to use a 4-point Likert scale (3: not at all; 2: a little; 1: quite a bit; 0: very much) to rate if/how their ALS impacts ten hypothetical communicative situations. Participants total scores were then added together, ranging from 0-30, and converted to a T-score ranging from 24.2-71.0. High scores are more favorable, indicating that the participant feels that ALS impacts their communicative participation less than those with lower scores.
Change From Baseline to Post-Treatment in ALS Quality of Life Scale
The ALS Quality of Life Scale-Revised (ALSQOL-R) (Simmons, 2015) was used to measure how ALS impacts their quality of life in six domains: negative emotion, interaction with people and the environment, intimacy, religiosity, physical symptoms, and bulbar function. Participants rate whether they strongly disagree (0) or strongly agree (10) with 46 statements. Each domain score is given an average value between 0 (worse) and 10 (best). Total scores on the ALSQOL-R range from 0-460, but an average score ranging from 0-10 is computed by dividing the total score by the total number of items completed by the participant (usually 46). Higher scores reflect a higher quality of life. A survey assessing how each participant feels ALS impacts quality of life, and how that changes throughout the study duration. Total scores range from 0-460, with higher scores indicating greater contributions of ALS to quality of life.
ALS Function Rating Scale Revised
A survey that quantifies change in disease progression throughout the study duration. Participants rate how 12 physical functions are impacted by their ALS. For each function, participants are provided with a 4-point Likert scale to rate whether they still have complete control of that function (4) or no ability to perform that function (0). Total scores range from 0 to 48, with lower scores indicating more severe symptoms and higher scores and less severe symptoms.
Psychosocial Impact of Assistive Devices Scale
A survey assessing how the training device/modality impacts patient's psychosocial functions. The PIADS includes 12 items for competence, 6 for adaptability, and 8 for self-esteem. Participants use a 7-point Likert scale to rate the impact of a device on each item: a maximum negative impact (-3), somewhat negative impact (-2 or -1), zero impact (0), somewhat positive impact (1 or 2), maximum positive impact (3). Total scores range from -78 (maximum negative impact) to 78 (maximum positive impact).
Tele-health Session Attendance
% of training sessions scheduled and attended by participants throughout the study duration
Adherence to Training Protocol
Number of of training exhalations completed (25 exhalations into the device, 5 days per week) by participants throughout the study duration

Full Information

First Posted
July 6, 2021
Last Updated
June 6, 2023
Sponsor
Purdue University
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
search

1. Study Identification

Unique Protocol Identification Number
NCT05003167
Brief Title
Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS
Official Title
Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
January 1, 2021 (Actual)
Primary Completion Date
June 1, 2022 (Actual)
Study Completion Date
June 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Purdue University
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of their homes for 6 weeks.
Detailed Description
The investigators are looking for people with early stage ALS to participate in a completely tele-health (no in-person visits required) treatment study examining the effects of an Expiratory Muscle Strength Training device (EMST-150) on communication, cough, and respiratory strength. Participants will be required to attend 2 virtual baseline assessment sessions followed by 12 additional virtual training sessions (2 per week for 6 weeks). Participants should plan to be actively enrolled in the study for ~10 weeks (3 weeks of baseline monitoring followed by 6 weeks of training). Participants will also be required to fill out a series of questionnaires assessing the EMST's effectiveness via tele-health.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amyotrophic Lateral Sclerosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All participants enrolled will receive the intervention.
Masking
None (Open Label)
Allocation
N/A
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Expiratory Muscle Strength Training
Arm Type
Experimental
Arm Description
All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).
Intervention Type
Device
Intervention Name(s)
Expiratory Muscle Strength Training (EMST-150)
Intervention Description
All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).
Primary Outcome Measure Information:
Title
Change From Baseline to Post-treatment for Maximum Expiratory Pressure
Description
Change in expiratory muscle strength throughout the study duration measured by the participant blowing into a pressure meter
Time Frame
Baseline 2 (week 2), Pre-Training (week 3), and Post-Training (week 10)
Secondary Outcome Measure Information:
Title
Peak Expiratory Flow Rate
Description
Change in cough strength (as measured by peak expiratory flow rate) throughout the study duration, measured using a flow meter that the participant coughs into - single coughs. Data from baseline 2 and pre-training were averaged for the pre--training value.
Time Frame
Baseline 2 (week 2), Pre-training (week 3), Post-Training (week 10)
Title
Change From Baseline to Post-Treatment in Utterance Length
Description
Change in utterance length (# of syllables produced on one breath) throughout the study duration. Participant read the Rainbow Passage and data were collected from this task.
Time Frame
Baseline 1 (week 1) and Post-Training (week 10)
Title
Change From Baseline to Post-Treatment in Number of Pauses
Description
Change in the total number of pauses that included breathing (breath pauses). Participant read the Rainbow Passage and data were collected from this task.
Time Frame
Baseline 1 (week 1) and Post-Training (week 10)
Title
Change From Baseline to Post-Treatment in Syntactic Location of Pauses
Description
Change in the location of pauses while breathing produced while reading. We determined where participants took breaths while reading the Rainbow Passage and categorized them according to syntax. Categories included at a major boundary (at the end of an independent clause marked by a period) and at a boundary that is not related to syntax (not a major or minor syntactical location). The number of pauses at each category of boundaries were converted to a percent of the total breaths taken while reading the passage.
Time Frame
Baseline 1 (week 1) and Post-Training (week 10)
Title
Telehealth Satisfaction
Description
Participants rated 15 statements with a 5-point Likert scale ranging from strongly disagree (1) to strongly agree (5). Example statements include: I can easily talk to my health-care provider, I can hear my health-care provider clearly, I can see my health-care provider as if we met in person, I think the care provided via telemedicine is consistent, and I receive adequate attention, telemedicine provides for my health care need, and overall, I am satisfied with the quality of service being provided via telemedicine. Total scores range from 0-75 and individual statement scores ranged from 1-5, with higher scores indicating higher satisfaction with the telepractice modality.
Time Frame
Post-Training (week 10)
Title
Change From Pre-Training to Post-Training in Communication Participation Item Bank
Description
Participants were instructed to use a 4-point Likert scale (3: not at all; 2: a little; 1: quite a bit; 0: very much) to rate if/how their ALS impacts ten hypothetical communicative situations. Participants total scores were then added together, ranging from 0-30, and converted to a T-score ranging from 24.2-71.0. High scores are more favorable, indicating that the participant feels that ALS impacts their communicative participation less than those with lower scores.
Time Frame
Pre-Training (week 3) and Post-Training (week 10)
Title
Change From Baseline to Post-Treatment in ALS Quality of Life Scale
Description
The ALS Quality of Life Scale-Revised (ALSQOL-R) (Simmons, 2015) was used to measure how ALS impacts their quality of life in six domains: negative emotion, interaction with people and the environment, intimacy, religiosity, physical symptoms, and bulbar function. Participants rate whether they strongly disagree (0) or strongly agree (10) with 46 statements. Each domain score is given an average value between 0 (worse) and 10 (best). Total scores on the ALSQOL-R range from 0-460, but an average score ranging from 0-10 is computed by dividing the total score by the total number of items completed by the participant (usually 46). Higher scores reflect a higher quality of life. A survey assessing how each participant feels ALS impacts quality of life, and how that changes throughout the study duration. Total scores range from 0-460, with higher scores indicating greater contributions of ALS to quality of life.
Time Frame
Baseline 1 (week 1) and Post-Training (week 10)
Title
ALS Function Rating Scale Revised
Description
A survey that quantifies change in disease progression throughout the study duration. Participants rate how 12 physical functions are impacted by their ALS. For each function, participants are provided with a 4-point Likert scale to rate whether they still have complete control of that function (4) or no ability to perform that function (0). Total scores range from 0 to 48, with lower scores indicating more severe symptoms and higher scores and less severe symptoms.
Time Frame
Baseline 1 (week 1) and Post-Training (week 10)
Title
Psychosocial Impact of Assistive Devices Scale
Description
A survey assessing how the training device/modality impacts patient's psychosocial functions. The PIADS includes 12 items for competence, 6 for adaptability, and 8 for self-esteem. Participants use a 7-point Likert scale to rate the impact of a device on each item: a maximum negative impact (-3), somewhat negative impact (-2 or -1), zero impact (0), somewhat positive impact (1 or 2), maximum positive impact (3). Total scores range from -78 (maximum negative impact) to 78 (maximum positive impact).
Time Frame
Post-treatment (week 10)
Title
Tele-health Session Attendance
Description
% of training sessions scheduled and attended by participants throughout the study duration
Time Frame
Measured at the end of training across the entire training period
Title
Adherence to Training Protocol
Description
Number of of training exhalations completed (25 exhalations into the device, 5 days per week) by participants throughout the study duration
Time Frame
Measured each week of training across the entire training duration

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of ALS Within the early stages of disease progression (i.e., able to talk, breathe, and eat independently) Speaker of English Have a family member/caregiver willing to assist as needed Have access to an electronic device and internet for tele-health Exclusion Criteria: A history of neurological disease (besides ALS) A history of asthma or respiratory problems (e.g., COPD, emphysema) A history of head, neck, or chest surgery (except mastectomy) A history of smoking within the last 5 years Reliance on mechanical ventilation (including CPAP)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jessica E Huber, Ph.D.
Organizational Affiliation
Purdue University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Purdue University
City
West Lafayette
State/Province
Indiana
ZIP/Postal Code
47906
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS

We'll reach out to this number within 24 hrs